“Levetiracetam plus Oxcarbazepine Combination Treatment Downregulates Serum Multidrug Resistance Protein 1 Levels and Upregulates Neuropeptide Y Levels in Children with Epilepsy”, Braz. J. Pharm. Sci., vol. 59, p. e21414, May 2023, doi: 10.1590/s2175-97902023e21414.